Poon Myra S, Chan Albert K F, Cusumano Janine M, Craig Maria E, Donaghue Kim C
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Discipline of Paediatrics and Child Health, University of Sydney, Sydney, New South Wales, Australia.
Pediatr Diabetes. 2024 Apr 12;2024:8194756. doi: 10.1155/2024/8194756. eCollection 2024.
Microvascular complications increase the risk of cardiovascular disease and premature death in adults with type 1 diabetes. We examined the association between microvascular complications during adolescence, including cardiac autonomic nerve dysfunction and subsequent mortality. . We undertook data linkage with the Australian National Death Index in a cohort of 409 adolescents (diagnosed between 1973 and 1993), 48% male, median age at final complications assessment 17.4 years (interquartile range: 16.0-18.9), followed longitudinally for median 22.3 years (21.0-23.4) from diagnosis. Generalized estimating equations (GEE) were used to examine associations between mortality and adolescent complications. Mortality risk was calculated as standardized mortality ratio (SMR).
At final adolescent visit, 20% had CAN abnormality, 30% abnormal pupillary response, 20% albuminuria, 40% early elevation of albumin excretion rate (AER) and 45% retinopathy. Data linkage 8-13 years later showed 14 were deceased (3% of cohort), 57% male, median age 28.3 years (24.8-32.9). Acute or chronic diabetes complications accounted for 25% of deaths. In multivariable GEE, elevated AER (OR 4.54, 1.23-16.80, =0.030), pupillary abnormality (OR 4.27, 1.20-15.22, =0.023), systolic blood pressure SDS (OR 2.17, 1.26-3.74, =0.005) and CAN (OR 4.65, 1.03-21.0, =0.045) predicted mortality. HbA1c was not significant. SMR was 2.5 (1.4-4.2) and was higher in females (SMR 3.5, 1.3-7.8) but not in males (SMR 2.1, 0.9-4.0).
Mortality in young adults with type 1 diabetes is predicted by subclinical markers of autonomic neuropathy and elevated AER during adolescence, but not glycemia. Mortality was over twice that of the background population in females but not in males.
微血管并发症会增加1型糖尿病成年患者患心血管疾病和过早死亡的风险。我们研究了青少年时期的微血管并发症(包括心脏自主神经功能障碍)与后续死亡率之间的关联。我们对409名青少年(1973年至1993年间确诊)进行了数据链接,这些青少年来自澳大利亚国家死亡指数队列,其中48%为男性,最终并发症评估时的中位年龄为17.4岁(四分位间距:16.0 - 18.9岁),自诊断后纵向随访中位时间为22.3年(21.0 - 23.4年)。使用广义估计方程(GEE)来研究死亡率与青少年并发症之间的关联。死亡率风险计算为标准化死亡率(SMR)。
在青少年最后一次就诊时,20%有心脏自主神经功能异常,30%瞳孔反应异常,20%有蛋白尿,40%白蛋白排泄率(AER)早期升高,45%有视网膜病变。8 - 13年后的数据链接显示有14人死亡(占队列的3%),其中57%为男性,中位年龄28.3岁(24.8 - 32.9岁)。急性或慢性糖尿病并发症占死亡原因的25%。在多变量GEE分析中,AER升高(比值比4.54,1.23 - 16.80,P = 0.030)、瞳孔异常(比值比4.27,1.20 - 15.22,P = 0.023)、收缩压标准差评分(比值比2.17,1.26 - 3.74,P = 0.005)和心脏自主神经功能障碍(比值比4.65,1.03 - 21.0,P = 0.045)可预测死亡率。糖化血红蛋白无显著意义。SMR为2.5(1.4 - 4.2),女性的SMR更高(SMR 3.5,1.3 - 7.8),但男性并非如此(SMR 2.1,0.9 - 4.0)。
1型糖尿病青年患者的死亡率可通过青少年时期自主神经病变的亚临床标志物和升高的AER来预测,但不能通过血糖水平预测。女性的死亡率是背景人群的两倍多,而男性并非如此。